Johnson & Johnson boosted its profit forecast for the year on Tuesday after post...
) boosted its profit forecast for the year on Tuesday after posting better-than-expected quarterly earnings on stronger prescription sales of its psoriasis treatment Stelara and cancer drug Imbruvica.
J&J shares have been under pressure this year, widely underperforming the S&P healthcare sector .SPXHC, as the company faces more than 13,000 lawsuits tied to antipsychotic drug Risperdal as well as a range of lawsuits involving its baby powder, opioids, medical devices and other products. J&J’s pharmaceuticals business has in recent years cushioned the impact of relatively slow growth in its other medical device and consumer units even as some of the company’s older drugs face competition from cheaper versions.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
J&J beats third-quarter earnings expectations on higher prescription drug salesJ&J's pharmaceutical business, which accounts for half of the company's revenue, posted revenue of $10.88 billion.
続きを読む »
DEA, amid backlash to proposed cuts to opioid production, responds to pain victims: We don't 'regulate the practice of medicine'After hundreds of chronic pain patients begged the Drug Enforcement Administration to reconsider its proposed cuts to opioid production, the agency told Newsweek it's not responsible for their inability to get prescriptions.
続きを読む »
JPMorgan Third-Quarter Profit Rises 8%JPMorgan Chase, the nation’s largest bank by assets, reported higher revenue and profit in the third quarter, sending its shares higher in premarket trading.
続きを読む »
Ruby Rose Details Amnesia, Suicide Attempt and PTSD in Candid Instagram PostRuby Rose shared her struggles with mental illnesses for World Mental Health Day.
続きを読む »
Aphria shares rocket 22% premarket after company posts surprise Q1 profitU.S.-listed shares of Canadian cannabis company Aphria Inc. rose 22% in premarket trade Tuesday, after the company posted a profit for its fiscal first...
続きを読む »
Apple set to reclaim market-cap title from Microsoft for first time in 6 monthsShares of Apple Inc. rose 0.6% in morning trading Monday, enough for the technology giant to reclaim the No. 1 spot on the list of largest U.S. companies by...
続きを読む »